When researchers discovered enough proof that a medication used to treat bone marrow cancer and Kaposi sarcoma is safe and effective in treating hereditary hemorrhagic telangiectasia (HHT), a rare bleeding disorder that affects 1 in 5,000 people worldwide, they decided to terminate an early
A new genetic test can identify dogs at risk of a potentially fatal condition that causes excessive bleeding and bruising in the hours and days after surgery.
Washington [US], July 24 (ANI): A study involving UCL researchers found that a single gene therapy injection can dramatically reduce the bleeding risk faced by people with haemophilia B.
Washington D.C [US], Dec. 4 (ANI): In a recent research presented at the 58th ASH Annual Meeting, scientists have reported the highest and most sustained levels of the essential blood-clotting factor in patients with the inherited bleeding disorder, hemophilia B.